Clinical Trial Update: Premedication With Intranasal Dexmedetomidine or Midazolam for Prevention of Emergence Agitation in Children [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating intranasal dexmedetomidine or intranasal midazolam as premedication to prevent emergence agitation in children; the study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Emergence Delirium

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Midazolam (Midazolam)

Snippet

Sponsor: Brasilia University Hospital | Conditions: Emergence Delirium | Phase 3 | Status: COMPLETED